University of Hertfordshire

UK bio pharma: Innovation re invention and capital at risk

Research output: Book/ReportCommissioned report

  • Colin Haslam
  • N. Tsitsianis
  • Pauline Gleadle
View graph of relations
Original languageEnglish
PublisherInstitute of Chartered Accountants of Scotland
Number of pages57
ISBN (Print)978-1-904574-79-8
Publication statusPublished - Jul 2011

Abstract

Small and medium enterprise (SME) bio-pharmas play a significant role
in the development of a knowledge-based competitive economy because
they act as an incubator of creativity for the development of pharmabased
products which they steer towards regulatory approval. Their
contribution is predominantly the development of new pharmaceutical
products which can then be licensed or sold on to big-pharma.

ID: 774090